Search results
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 2 days agoLess promisingly, on April 10, Lilly said patients who received its diabetes drug, Jardiance, after...
Why Is Eli Lilly Stock Trading Higher On Tuesday? - Eli Lilly and Co (NYSE:LLY)
Benzinga· 2 days agoThe volume increase was primarily driven by growth from Mounjaro, Zepbound, Verzenio, and Jardiance,...
IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Investor's Business Daily· 2 days agoHe kept his in-line (neutral) rating on Eli Lilly stock. Sales of other key products, cancer drug...
Eli Lilly’s stock jumps as first-quarter profit tops estimates amid strong sales of Mounjaro,...
Market Watch· 2 days agoEli Lilly & Co. shares gained 7% premarket on Tuesday after the company reported first-quarter...
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Zacks· 2 days agoEli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises...
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 day agoThese products have shown strong performance and are backed by a robust pipeline of approximately 50...
Analyst Report: Eli Lilly and Company
Morningstar Research via Yahoo Finance· 2 days agoEli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound,
Lilly sees quarterly profit jump 67% on demand for new weight-loss drugs - Indianapolis Business...
Indianapolis Business Journal· 2 days agoEli Lilly and Co. said Tuesday that “exceptionally strong demand” for diabetes drugs Mounjaro and...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 7 days agoThe stock has surged 52.5% in the past year. Eli Lilly: Its revenue growth is being driven by higher...
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
Zacks via Yahoo Finance· 20 hours agoEli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity...